Next Generation Sequencing in Precision Medicine Market Size and Revenue Impact Study 2025 to 2034

Report Id: 3157 Pages: 180 Last Updated: 17 December 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Next-Generation Sequencing in Precision Medicine Market -

Next-Generation Sequencing in Precision Medicine Market by Product & Service-

  • NGS Services
  • Sequencing Instruments
  • Consumables & Reagents
  • Bioinformatics Software
  • Library Preparation Kits

next generation sequencing precesion medicine

Next-Generation Sequencing in Precision Medicine Market by Technology -

  • RNA Sequencing
  • Whole Genome Sequencing (WGS)
  • Targeted Sequencing
  • Whole Exome Sequencing (WES)
  • Single-Cell Sequencing

Next-Generation Sequencing in Precision Medicine Market by Application-

  • Infectious Disease
  • Rare & Inherited Disorders
  • Pharmacogenomics
  • Oncology (Cancer Genomics)
  • Prenatal and Reproductive Health

Next-Generation Sequencing in Precision Medicine Market by End-use-

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Biopharmaceutical Companies
  • Academic & Research Institutions
  • CROs (Contract Research Organizations)

Next-Generation Sequencing in Precision Medicine Market by Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Next-Generation Sequencing in Precision Medicine Market Snapshot

Chapter 4. Global Next-Generation Sequencing in Precision Medicine Market Variables, Trends & Scope

4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends 
4.5. Investment and Funding Analysis 
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034  
4.8. Global Next-Generation Sequencing in Precision Medicine Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on NEXT-GENERATION SEQUENCING IN PRECISION MEDICINE MARKET Industry Trends 

Chapter 5. Next-Generation Sequencing in Precision Medicine Market Segmentation 1: By Technology, Estimates & Trend Analysis

5.1. Market Share by Technology, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:

5.2.1. Whole Genome Sequencing (WGS)
5.2.2. Whole Exome Sequencing (WES)
5.2.3. Targeted Sequencing
5.2.4. RNA Sequencing
5.2.5. Single-Cell Sequencing

Chapter 6. Next-Generation Sequencing in Precision Medicine Market Segmentation 2: By Application, Estimates & Trend Analysis

6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

6.2.1. Oncology (Cancer Genomics)
6.2.2. Infectious Disease
6.2.3. Rare & Inherited Disorders
6.2.4. Prenatal and Reproductive Health
6.2.5. Pharmacogenomics

Chapter 7. Next-Generation Sequencing in Precision Medicine Market Segmentation 3: By Product & Service, Estimates & Trend Analysis

7.1. Market Share by Product & Service, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product & Service:

7.2.1. Sequencing Instruments
7.2.2. Consumables & Reagents
7.2.3. Library Preparation Kits
7.2.4. Bioinformatics Software
7.2.5. NGS Services

Chapter 8. Next-Generation Sequencing in Precision Medicine Market Segmentation 4: By End Use, Estimates & Trend Analysis

8.1. Market Share by End Use, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Use:

8.2.1. Hospitals & Clinics
8.2.2. Academic & Research Institutions
8.2.3. Biopharmaceutical Companies
8.2.4. Diagnostic Laboratories
8.2.5. CROs (Contract Research Organizations)

Chapter 9. Next-Generation Sequencing in Precision Medicine Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. Global Next-Generation Sequencing in Precision Medicine Market, Regional Snapshot 2024 & 2034
9.2. North America

9.2.1. North America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.2.1.1. US
9.2.1.2. Canada

9.2.2. North America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.3. North America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.2.5. North America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034

9.3. Europe

9.3.1. Europe Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe

9.3.2. Europe Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.3. Europe Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.3.5. Europe Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034

9.4. Asia Pacific

9.4.1. Asia Pacific Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.4.1.1. India 
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific

9.4.2. Asia Pacific Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.3. Asia Pacific Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.4.5. Asia Pacific Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034

9.5. Latin America

9.5.1. Latin America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America

9.5.2. Latin America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.3. Latin America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.5.5. Latin America Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034

9.6. Middle East & Africa

9.6.1. Middle East & Africa Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa

9.6.2. Middle East & Africa Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.6.3. Middle East & Africa Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
9.6.5. Middle East & Africa Next-Generation Sequencing in Precision Medicine Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
 
10.2.1. Illumina
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service 
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Thermo Fisher Scientific
10.2.3. Roche
10.2.4. Danaher
10.2.5. QIAGEN
10.2.6. Agilent Technologies
10.2.7. Eurofins Scientific
10.2.8. Pacific Biosciences (PacBio)
10.2.9. Oxford Nanopore Technologies
10.2.10. Takara Bio
10.2.11. BGI Group (MGI Tech)
10.2.12. Merck KGaA
10.2.13. BD (Becton, Dickinson and Company)
10.2.14. 10x Genomics
10.2.15. New England Biolabs
10.2.16. Promega Corporation
10.2.17. Revvity (formerly PerkinElmer)
10.2.18. Zymo Research
10.2.19. Novogene
10.2.20. LGC Limited

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7179
Security Code field cannot be blank!

Frequently Asked Questions

Next-Generation Sequencing in Precision Medicine Market Size is valued at US$ 1.3 Bn in 2024 and is predicted to reach US$ 7.5 Bn by the year 2034

Next-Generation Sequencing in Precision Medicine Market is expected to grow at a 19.7% CAGR during the forecast period for 2025 to 2034.

Major players in the Next-Generation Sequencing in Precision Medicine market are Danaher, Thermo Fisher Scientific, Agilent Technologies, Eurofins Sc

Primary Next-Generation Sequencing in Precision Medicine market segments are Product & Service, Technology, Application, and End-use.

North America region is leading the Next-Generation Sequencing in Precision Medicine Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying